top of page
EPOCH
Oral Semaglutide in Patients with Type 2 Diabetic (T2D): Reducing Risk of Heart Failure (HF)
BY:
Andrew Chan
Oral Semaglutide in Patients with Type 2 Diabetic (T2D): Reducing Risk of Heart Failure (HF)



POPULAR STORY
bottom of page
.png)













